Analystreport

Milestone Pharmaceuticals (NASDAQ:MIST) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $4.00 price target on the stock.

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report